Feb 3 (Reuters) - United Therapeutics Corp UTHR.O:
UNITED THERAPEUTICS CORPORATION ANNOUNCES FDA CLEARANCE OF ITS INVESTIGATIONAL NEW DRUG APPLICATION FOR THE UKIDNEY XENOTRANSPLANTATION CLINICAL TRIAL
UNITED THERAPEUTICS CORP - FIRST XENOTRANSPLANT EXPECTED AROUND MID-YEAR 2025
Source text: ID:nBw73NtjRa
Further company coverage: UTHR.O
((Reuters.Briefs@thomsonreuters.com;))